Babraham Bioscience Technologies Ltd (BBT) today announced the initiation of a new bioincubator building programme at the Babraham Research Campus, further expanding Babraham’s capacity for supporting early-stage companies and biomedical innovation.
Babraham announces new bioincubator building programme for 2010
SDC Builders Ltd have been appointed as the main contractor for the construction of the new Bioincubator facility at the Babraham Research Campus. The new 8800 sq ft facility is designed to provide accommodation for up to 16 early stage biomedical companies at the heart of the Cambridge Biomedical cluster.
The building has been designed to allow maximum flexibility in use so that combinations of office, laboratory, cell culture and containment level 2 facilities can readily be provided according to the specific needs of early stage companies.
The Babraham Institute, an independent charitable organisation located six miles south-east of Cambridge, is an institute of the Biotechnology and Biological Sciences Research Council. Carrying out world-leading innovative research and advanced training with relevance to the biomedical, biotechnological, pharmaceutical and healthcare communities, the institute underpins government’s national responsibilities for healthcare research and training. Research focuses on the mechanisms of cell signalling and gene regulation, which underlie normal cellular processes and functions, and on how their failure or abnormality may lead to disease. The latest technologies are being used to study the basis of conditions such as neurodegenerative disorders, foetal abnormality, cancer and diseases of the immune and cardiovascular systems. The commercialisation of the Institute’s research is managed by its trading subsidiary, Babraham Bioscience Technologies Ltd. Website: www.babraham.ac.uk
The Institute is an independent charitable life sciences research institute, strategically funded by the Biotechnology and Biological Sciences Research Council.